All News

Inflammatory disease biotech Ventyx Biosciences sets terms for $125 million IPO

Ref: Renaissance Capital

Tags: NewsPoints Ventyx Psoriasis Arthritis IBD Corporate Affairs VTX958

New CDC data shows the risk of dying from Covid-19 is 11 times higher for unvaccinated adults than for fully vaccinated adults

Ref: CNN

Tags: NewsPoints COVID-19 Immunisation CDC Clinical Research (R&D) Medical Affairs

Unique underpinnings revealed for stomach’s acid pump: New understandings of a stomach enzyme could lead to better anti-ulcer drugs.

Ref: Nagoya University

Tags: Press Release H. Pylori/Ulcer Clinical Research (R&D)

Statins linked to reduced risk of death from COVID-19 in major population study

Ref: Karolinska Institutet

Tags: Press Release Karolinska Institutet COVID-19 Clinical Research (R&D) Medical Affairs dexamethasone

Gay, bisexual Canadians using off-label medications to prevent STIs

Ref: CTV News

Tags: NewsPoints GSK STDs Immunisation Health Canada Clinical Research (R&D) Medical Affairs Bexsero

OU Researchers Contribute to Study on Possible Alternative Treatment for Lyme Disease

Ref: University of Oklahoma

Tags: Press Release Viral Infections Clinical Research (R&D)

Bone-loss discovery points to new treatment for osteoporosis

Ref: University of Virginia Health System

Tags: Press Release Osteoporosis Clinical Research (R&D)

COVID-19 Vaccine AstraZeneca - Important Safety Information from AstraZeneca (Ireland) DAC as approved by the HPRA (13.10.21)

Ref: HPRA

Tags: Press Release AstraZeneca European Union COVID-19 Immunisation HPRA Marketing & Sales Medical Affairs Regulatory Affairs

Buprenorphine misuse decreased among U.S. adults with opioid use disorder from 2015-2019

Ref: NIH

Tags: Press Release Addictions Pain Management CDC HHS NIH Clinical Research (R&D) Medical Affairs buprenorphine

OPSYNVI (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)

Ref: Johnson &, Johnson

Tags: Press Release J&J Pulmonary Hypertension Health Canada Regulatory Affairs Marketing & Sales macitentan tadalafil Opsynvi